Summary.-Pre-treatment with the anabolic steroid nandrolone decanoate (ND) increases the LD50 of 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea (CCNU) and 5-Fluorouracil (FU) in NMRI mice. Administration of ND did not affect the antitumour action of CCNU against a transplantable mouse adenocarcinoma of the colon (MAC 13) or the anti-tumour action of FU against MAC 26. In both tumour lines ND had no significant effect on tumour growth. These data suggest that an increase in the anti-tumour selectivity of these agents may be produced by pretreatment with ND.
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THE EFFICACY OF CHEMOTHERAPY is limited by the small margin between tumour kill and serious host toxicity. More effective therapy might be achieved if toxicity in normal tissues could be reduced without altering the anti-tumour activity of the drug. One approach is to produce new, more selective drugs, the other to protect the host against the undesirable effects of the agents currently available.
It has been reported that simultaneous administration of a steroid (testosterone) with cytotoxic therapy for advanced breast cancer, reduced marrow toxicity without apparently influencing the antitumour activity (Whyte Watson & Turner, 1959 Turner, 1966; Rawbone & Bagshaw, 1972; Edelstyn et al., 1979; Spiers & Allar, 1979) .
It has been shown recently that administration of testosterone can protect against host toxicity without interfering with the anti-cancer activity of FU in a primary syngeneic CD8F1 breast-tumour system (Stolfi et al., 1980) . Preliminary studies (Double & Bibby, 1980) Murine tunaour system. (transplantable adenocarcinomas of the colon). Pure-strain NMRI mice (age 6-8 weeks) from our inbred colony were used. The development of several transplantable adenocarcinomas of the large bowel in mice from primary tumours induced by prolonged administration of 1,2-dimethylhydrazine has been described elsewhere . Two of these lines (MAC 13 and MAC 26) were used in this study. Studies on the growth characteristics, histopathology and chemotherapy of earlier passages of these tumours have been previously reported com- parison of the ratios of treated tumour weights to control tumour weight (T/C) from combined semi-log plots of toxicity and antitumour activity.
MAC 26: 2-3 weeks after transplantation, tumours were selected according to the method of and tumourbearing mice were randomized into groups of 8. Chemotherapy commenced on Day 0, and its effects were assessed by serial, twiceweekly, two-dimensional caliper measurements. Tumour volume was calculated from the formula a2 x b/2, where a is the smallest diameter and b is the larger (Geran et al., 1972) . Tumour volumes were normalized with respect to their starting volumes and semi-log plots were drawn of relative tumour volume (RTV) against time. All injections were i.p. Nandrolone decanoate (ND) (supplied by Organon Laboratories Limited, U.K.) was dissolved in arachis oil. CCNU (supplied by Dr J. M. Venditti, NCI) was dissolved in 10% ethanol/arachis oil and FU (supplied by Roche, Welwyn Garden City, U.K.) was dissolved in 0.85% NaCl. In all cases the drugs were dissolved at an appropriate concentration for a desired dose to be administered in 0-1 ml/10 g body weight. It was originally intended to give ND at maximum tolerated dose. Since it was impossible to determine an LD50 for ND it was decided that a clinically equivalent dose of 50 mg/kg would be used.
Total white-cell counts.-Groups of 5 male mice were bled from the orbital sinus using 44 7u1l Accupets (Coulter Electronics) and total WBC determined using a Coulter S plus counter.
RESULTS

LD50 determination
The effects of ND on the LD50 values of CCNU and FU in NMRI mice are presented in Fig. 1 the LD50 in this system was 165 mg/kg. Fig. 5 illustrates the effect of 10-day pretreatment with ND in this system. The growth curves for the ND-treated groups are essentially the same as those of the non-ND treated ones seen in Fig. 4 (Hershberger et al., 1953; Barnes et al., 1954) . Because of the different modes of action of the two cytotoxic agents used in this study and various observations in the literature, it seems most logical to assume that the beneficial effects of anabolic steroid therapy are host-mediated rather than the result of complex metabolic interactions. Udupa & Reissmann (1974) have described enhanced granulopoietic recovery in mice made neutropenic by 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU), vinblastine or cyclophosphamide, with concurrent treatment with testosterone, oxymethalone or ND. Similar observations have been made in the present study with CCNU and ND pre-treatment. It is interesting to note that our observations were made with single injections of ND compared with daily injections by Udupa & Reissmann. All too often potentially successful chemotherapy has to be curtailed due to the lifethreatening host toxicity of the agents used. We have shown that it is possible to reduce the host toxicity of two standard agents with differing modes of action without loss of anti-tumour activity. In our experimental system the difference in cytotoxic susceptibility between the host and the tumours is slight, but even a small reduction in host toxicity produces a significantly improved therapeutic effect. If such observations were borne out in the clinic with such widely used agents as CCNU and FU, this would present a significant advance in the management of metastatic disease. Current work is directed towards elucidating the mechanism of host protection exhibited by ND with a view to determining its more effective use in conjunction with a variety of standard regimens.
